South America Plasma Fractionation Market Research Report By Product Type (Immunoglobulin, Albumin, Coagulation Factors, Protease Inhibitors), By Application (Neurology, Hematology, General Medicine, Immunology), By End User (Hospitals, Ambulatory Surgical Centers, Blood Banks, Pharmaceutical Companies), By Technology (Centrifugation, Chromatography, Precipitation, Filtration) and By Regional (Brazil, Mexico, Argentina, Rest of South America)-Forecast to 2035

South America Plasma Fractionation Market Overview

As per MRFR analysis, the South America Plasma Fractionation Market Size was estimated at 2.27 (USD Billion) in 2024.The South America Plasma Fractionation Market Industry is expected to grow from 2.84(USD Billion) in 2025 to 5.82 (USD Billion) by 2035. The South America Plasma Fractionation Market CAGR (growth rate) is expected to be around 6.74% during the forecast period (2025 - 2035).

Key South America Plasma Fractionation Market Trends Highlighted

The South America Plasma Fractionation Market is witnessing notable trends driven by increasing demand for immunoglobulins and albumin, largely due to the rising prevalence of chronic diseases and the need for advanced therapeutic options. Countries like Brazil and Argentina are enhancing their healthcare infrastructure, which boosts the demand for plasma-derived products. The growing focus on biopharmaceuticals is also a significant market driver, as local governments support initiatives for innovation in biotechnology, indicating a shift towards developing domestic production capabilities to reduce reliance on imports.

Opportunities in the South American plasma fractionation space are expanding, particularly as regional players invest in advanced technologies to improve the quality and efficiency of plasma collection and processing.This presents a unique chance for collaboration between private sectors and public health initiatives. Additionally, the ongoing regulatory reforms aimed at improving plasma donation safety can increase public confidence, thereby encouraging more people to donate, which is vital for the sustainability of plasma supply chains.

Recent times have seen a shift in consumer attitudes, with greater awareness of the benefits of plasma-derived therapies fueling demand. Moreover, backup infrastructure to support the cold chain logistics for plasma products is being developed, enhancing distribution efficiency. There is also an emerging trend of partnerships between local firms and global players to facilitate knowledge transfer and technology exchange.This trend emphasizes the regional commitment to enhancing capabilities in plasma fractionation while ensuring that the increasing therapeutic needs of the population are met effectively and responsibly. Overall, the South America Plasma Fractionation Market is positioned for growth, driven by both demand and innovation in biotechnology.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South America Plasma Fractionation Market Drivers

Increasing Demand for Immunoglobulin Therapies

The South America Plasma Fractionation Market is witnessing a growing demand for immunoglobulin therapies, which are derived from human plasma and used to treat various autoimmune and immunodeficiency disorders. According to data from the Brazilian Health Ministry, the incidence of primary immunodeficiency diseases in Brazil is estimated to be as high as 1 in 2,000 individuals. This translates to approximately 100,000 potential patients in Brazil alone who may benefit from immunoglobulin therapies.

Additionally, organizations such as the Brazilian Society of Immunology are advocating for expanded access to these treatments, increasing awareness and demand in the region. The increased prevalence of conditions requiring immunoglobulin therapies is expected to significantly drive the South America Plasma Fractionation Market industry in the coming years.

Expansion of Healthcare Infrastructure

The improvement and expansion of healthcare infrastructure across South America are contributing to the growth of the South America Plasma Fractionation Market. For instance, the National Health Department of Argentina reported a 25% increase in the allocation of budget funds toward improving healthcare facilities and access to biopharmaceuticals in the past three years. This investment is enhancing the capacity for plasma collection and processing, leading to higher production capabilities for plasma-derived products.The improvement of healthcare facilities enables the industry to optimize the growing need for efficient and safe plasma therapies, thus helping the industry grow.

Rising Awareness and Acceptance of Plasma Therapies

There has been a significant increase in awareness and acceptance of plasma therapies among both healthcare professionals and patients in South America. A recent survey conducted by the Argentine Blood Transfusion Foundation revealed that approximately 65% of healthcare providers now recognize the therapeutic benefits of plasma-derived therapies. As a result, patients are increasingly seeking these treatments, leading to a more substantial demand for products derived from plasma fractionation.This growing awareness and acceptance are critical drivers for the growth of the South America Plasma Fractionation Market, as they encourage healthcare systems to invest more in these therapies.

South America Plasma Fractionation Market Segment Insights

Plasma Fractionation Market Product Type Insights

The South America Plasma Fractionation Market is diverse and includes various product types that cater to a range of medical needs. Among these product types, Immunoglobulin emerges as a significant segment, primarily used in treating immune deficiencies, autoimmune diseases, and inflammatory conditions, reflecting its indispensable role in therapeutic therapies. Albumin is another vital component derived from plasma, extensively utilized for various health issues, including carrying medications and fluids in the bloodstream, which indicates its pivotal role in patient care and recovery settings.Moreover, Coagulation Factors hold crucial importance in treating hemophilia and other bleeding disorders, underscoring the need for advanced treatments in the region, while Protease Inhibitors, though a smaller segment, are gaining attention for their potential role in treating various conditions, including certain viral infections.

The growing awareness of blood-related disorders and the rise in healthcare services across South America drives the demand for these product types. As the healthcare industry in the region evolves, providers are expected to leverage advances in plasma fractionation technology, significantly enhancing production efficacy and ensuring patient safety and care.Each of these product types plays a crucial role not only in treatment but also reflects the expanding healthcare infrastructure needed to meet the rising demand for plasma-derived therapies in South America.

The South America Plasma Fractionation Market segmentation highlights the importance of immunological research and innovation in producing effective therapies, shaping the overall industry's growth trajectory as science progresses. The increasing investment into healthcare initiatives further underscores the opportunities within this market, aiming to provide high-quality therapies that meet patient needs while enhancing health outcomes across the region.

The insights into these segments showcase a market that is robust, diverse, and inspired by the need for advanced therapeutic solutions and improved health services. Overall, understanding the dynamics of each product type is critical for stakeholders aiming to navigate the evolving landscape of the South America Plasma Fractionation Market as they seek to align with health trends and patient requirements in this increasingly important sector.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Plasma Fractionation Market Application Insights

The South America Plasma Fractionation Market is notably segmented into various applications, including Neurology, Hematology, General Medicine, and Immunology, each contributing to the region's healthcare development. Neurology is crucial due to the increasing prevalence of neurological disorders, providing essential therapies derived from plasma. In Hematology, plasma-derived immunoglobulins serve significant roles in treating blood conditions, reflecting the growing demand for blood products.

General Medicine encompasses a diverse range of treatments, reinforcing the importance of plasma fractionation in overall healthcare.Immunology continues to dominate as advancements in disease management and immunotherapies rise, reflecting significant growth within this sector. Collectively, these applications highlight the critical role of plasma fractionation in addressing prevalent health needs in South America, indicating a robust growth trajectory moving forward as healthcare facilities expand and technologies improve. Furthermore, regional initiatives aimed at enhancing healthcare accessibility and developing advanced medical facilities contribute to the South America Plasma Fractionation Market's momentum, ensuring the continuous support of diverse therapeutic areas.

Plasma Fractionation Market End User Insights

The South America Plasma Fractionation Market shows significant activity in the End User segment, which encompasses various critical sectors such as Hospitals, Ambulatory Surgical Centers, Blood Banks, and Pharmaceutical Companies. Hospitals represent a substantial portion of this market due to their extensive need for plasma-derived products in treatments and therapies for various ailments. Ambulatory Surgical Centers are increasingly gaining traction as they offer efficient and cost-effective healthcare solutions, further driving demand for plasma fractionation.Blood Banks play a crucial role in the collection and processing of plasma, serving as a vital source therapeutic proteins, which are essential for patients with clotting disorders.

Meanwhile, Pharmaceutical Companies significantly contribute to the market, leveraging advanced technologies in R&D to develop innovative plasma-based therapies. The growing prevalence of chronic diseases in South America, combined with the rising healthcare expenditure, presents numerous opportunities for expansion across these segments. Furthermore, the increasing awareness of the benefits of plasma products among healthcare providers and patients alike is driving market growth, underscoring the importance of each sector in meeting the region’s healthcare demands.

Plasma Fractionation Market Technology Insights

The South America Plasma Fractionation Market is witnessing significant growth driven by advancements in technology. The Technology segment encompasses various processes essential for the separation and purification of plasma proteins. Centrifugation remains crucial as it efficiently separates components based on density, making it vital for producing various therapeutic products. Chromatography is also important since it enables high-resolution separation, thereby enhancing product quality and efficacy, appealing to pharmaceutical companies focused on precision medicine.Precipitation methods are recognized for their cost-effectiveness and simplicity in isolating proteins, appealing to emerging biotech firms in South America.

Filtration techniques, notably membrane filtration, ensure high purity by removing contaminants, aligning with stringent regulatory standards in the healthcare industry. The South America Plasma Fractionation Market is supported by increasing investments in healthcare infrastructure and a growing emphasis on biotechnology, advancing these technologies. However, challenges like high operational costs and complex regulatory environments may require strategic innovation and collaboration, providing opportunities for growth and improvement in the efficiency of plasma fractionation processes.Overall, the demarcation of Technology in the plasma fractionation landscape illustrates a robust movement towards enhancing therapeutic capabilities and meeting the region's healthcare needs.

Plasma Fractionation Market Regional Insights

The South America Plasma Fractionation Market is witnessing notable growth, driven by increasing healthcare expenditure and advancements in biotechnology. Within the region, Brazil stands out as a dominant player, contributing significantly to market developments due to its large population and advanced medical infrastructure. Mexico also plays a crucial role, with growing investments in biopharmaceuticals and increasing awareness of plasma-derived therapies driving demand.

Argentina's emerging healthcare sector presents new opportunities, particularly as the country enhances its biomanufacturing capabilities.The Rest of South America segment showcases potential growth, reflecting innovations in healthcare access and increasing investments in research and development. The efficient management of plasma resources and government initiatives to improve healthcare quality further stimulate the market. Overall, the South America Plasma Fractionation Market segmentation highlights diverse opportunities across the region, each contributing to a robust growth trajectory influenced by regional needs and healthcare advancements.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South America Plasma Fractionation Market Key Players and Competitive Insights

The South America Plasma Fractionation Market has been evolving rapidly in recent years, propelled by increasing demand for immunoglobulins, clotting factors, and other derived therapeutics. The competitive landscape is characterized by a diverse set of players ranging from multinational corporations to specialized regional firms. Factors such as advanced technology integration, rising awareness regarding the therapeutic applications of plasma-derived products, and supportive government initiatives aimed at enhancing healthcare infrastructure are contributing to the dynamic nature of this market. Companies are engaged in strategic collaborations, partnerships, and innovation to enhance their market position and address the growing healthcare needs of the region. As the market matures, competition is intensifying, with companies constantly striving to maintain their edge through product development and operational efficiency.

Octapharma holds a prominent position in the South America Plasma Fractionation Market, with a strong focus on producing high-quality plasma-derived products. The company has established significant market presence due to its extensive product range, including human plasma-derived immunoglobulins and coagulation factor concentrates, addressing various health challenges in the region. Octapharma’s ability to leverage state-of-the-art technology in its fractionation processes enables it to maintain high standards of product quality and safety. Furthermore, the firm’s significant investment in research and development enhances its capacity to innovate and respond to the evolving therapeutic demands within the South American healthcare landscape.

The company's strong distribution network and established relationships with healthcare providers have further solidified its standing, allowing it to effectively cater to the unique needs of the local market.ImmunoPrecise Antibodies has carved a niche for itself in the South America Plasma Fractionation Market with a focus on monoclonal antibodies and custom antibody development services. The company’s expertise in providing specialized diagnostics and therapeutic solutions has positioned it favorably in this competitive landscape.

ImmunoPrecise Antibodies is recognized for its ability to leverage cutting-edge technologies and advanced methodologies in the production of antibody-based therapies, which meet the specific requirements of the healthcare sector in South America. The company's commitment to collaboration has led to strategic partnerships and mergers that bolster its market presence, enhancing research capabilities and broadening its service offerings. This focused approach not only strengthens ImmunoPrecise Antibodies’ role in the region but also underscores its potential to contribute significantly to the advancement of plasma-derived therapies tailored to the needs of South American patients.

Key Companies in the South America Plasma Fractionation Market Include

• Octapharma


• ImmunoPrecise Antibodies


• Biotest AG


• Grifols


• Prothera


• Takeda Pharmaceutical


• Sangamo Therapeutics


• CSL Behring


• Shire


• LFB


• Hematologic Technologies


• Hyaluronic Acid


• Fractionation Technologies


• Kedrion Biopharma

South America Plasma Fractionation Market Industry Developments

The South America Plasma Fractionation Market has seen significant developments recently, particularly in the growth and expansion of major companies like Grifols and Takeda Pharmaceutical. In September 2023, Grifols announced the opening of a new plasma collection center in Brazil, further solidifying its presence in the region. Meanwhile, Takeda Pharmaceutical has been actively investing in enhancing its plasma-derived therapies in South America to meet increasing local demand, indicative of a promising market environment. In terms of mergers and acquisitions, ImmunoPrecise Antibodies was involved in a notable acquisition in July 2023, adding valuable product lines that align with the company’s strategic goals in plasma-derived products. The market has also witnessed an increase in investments from CSL Behring, who aims to establish more facilities to enhance local production capabilities.

The steady growth of the South America plasma fractionation market can be attributed to an uptick in healthcare spending and advancements in processing technologies, promoting innovations among key players like Octapharma and Biotest AG as they adapt to the evolving market dynamics. This landscape facilitates increased access to vital therapies across the region, catering to both current and future healthcare needs.

South America Plasma Fractionation Market Segmentation Insights

Plasma Fractionation Market Product Type Outlook

• Immunoglobulin


• Albumin


• Coagulation Factors


• Protease Inhibitors

Plasma Fractionation Market Application Outlook

• Neurology


• Hematology


• General Medicine


• Immunology

Plasma Fractionation Market End User Outlook

• Hospitals


• Ambulatory Surgical Centers


• Blood Banks


• Pharmaceutical Companies

Plasma Fractionation Market Technology Outlook

• Centrifugation


• Chromatography


• Precipitation


• Filtration

Plasma Fractionation Market Regional Outlook

• Brazil


• Mexico


• Argentina


• Rest of South America

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	2.27 (USD Billion)
MARKET SIZE 2024	2.84 (USD Billion)
MARKET SIZE 2035	5.82 (USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.74% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Octapharma, ImmunoPrecise Antibodies, Biotest AG, Grifols, Prothera, Takeda Pharmaceutical, Sangamo Therapeutics, CSL Behring, Shire, LFB, Hematologic Technologies, Hyaluronic Acid, Fractionation Technologies, Kedrion Biopharma
SEGMENTS COVERED	Product Type, Application, End User, Technology, Regional
KEY MARKET OPPORTUNITIES	Increased demand for immunoglobulins, Expansion of healthcare infrastructure, Rising incidence of hematological disorders, Government support for biopharmaceuticals, Growth in aging population.
KEY MARKET DYNAMICS	rising demand for plasma products, increasing investment in healthcare, technological advancements in fractionation, growing prevalence of chronic diseases, supportive regulatory environment
COUNTRIES COVERED	Brazil, Mexico, Argentina, Rest of South America